Log in
Enquire now
‌

US Patent 9862946 Peptide oligonucleotide conjugates

Patent 9862946 was granted and assigned to Sarepta Therapeutics on January, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Sarepta Therapeutics
Sarepta Therapeutics
0
Current Assignee
Sarepta Therapeutics
Sarepta Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
98629460
Patent Inventor Names
Gunnar J. Hanson0
Date of Patent
January 9, 2018
0
Patent Application Number
148514340
Date Filed
September 11, 2015
0
Patent Citations Received
‌
US Patent 12013403 Compositions and methods for detection of SMN protein in a subject and treatment of a subject
0
Patent Primary Examiner
‌
Jane Zara
0
Patent abstract

Oligonucleotide analogs conjugated to carrier peptides are provided. The disclosed compounds are useful for the treatment of various diseases, for example diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9862946 Peptide oligonucleotide conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us